Antibody Engineering & Therapeutics
The Antibody Engineering & Therapeutics event, held December 13-16, 2023 at Marriott Marquis San Diego (Booth #405), will feature presentations on cutting-edge antibody research including neurodegenerative diseases, tumor microenvironment, bi-specifics, ADCs, and immuno-oncology, highlighted by a session on sequence and structure-based workflows for single-domain antibody diversity and developability assessments using Geneious Biologics tools, presented by Dr. Vinodh Kurella of Takeda and Dr. Monica Watson of Dotmatics.
Event Details
- Event: Antibody Engineering & Therapeutics
- Date: December 13-16, 2023
- Location: Marriott Marquis San Diego, Booth #405
Join us at the Antibody Engineering & Therapeutics event to explore the latest science and research on antibody engineering, design, and selection. The event will cover critical topics including:
- Neurodegenerative Diseases
- Tumor Microenvironment in Antibody Therapy
- Antibody Immune Agonist
- Bi-Specifics
- ADCs (Antibody-Drug Conjugates)
- Protein-Based Degraders
- Immuno-oncology
- T-Cells
- VHH (single-domain antibodies)
- And much more
Presentation:
Antibody Sequence and Structure-based Workflows for Diversity and Developability Assessments
This presentation will walk through sequence and structure-guided analyses of sdAbs (single-domain antibodies) from diverse public sources using tools such as Geneious Biologics. It will include clustering and visualizations of sdAbs based on CDR-H3 diversity and developability assessments, as well as a brief overview of the potential for AI to direct antibody engineering efforts.
Speakers include:
- Vinodh Kurella, PhD
Senior Scientist, Takeda - Monica Watson, PhD
Field Application Scientist, Geneious Biologics, Dotmatics